JPS5753410A - A type hepatitis virus high value production - Google Patents

A type hepatitis virus high value production

Info

Publication number
JPS5753410A
JPS5753410A JP56114522A JP11452281A JPS5753410A JP S5753410 A JPS5753410 A JP S5753410A JP 56114522 A JP56114522 A JP 56114522A JP 11452281 A JP11452281 A JP 11452281A JP S5753410 A JPS5753410 A JP S5753410A
Authority
JP
Japan
Prior art keywords
high value
hepatitis virus
type hepatitis
value production
virus high
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP56114522A
Other languages
English (en)
Japanese (ja)
Inventor
Zetsuto Maakasu Henrii
Jiee Makuaree Uiriamu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JPS5753410A publication Critical patent/JPS5753410A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/29Hepatitis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32411Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32411Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32451Methods of production or purification of viral material
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP56114522A 1980-07-23 1981-07-23 A type hepatitis virus high value production Pending JPS5753410A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/171,621 US4301249A (en) 1980-07-23 1980-07-23 High titer production of hepatitis A virus

Publications (1)

Publication Number Publication Date
JPS5753410A true JPS5753410A (en) 1982-03-30

Family

ID=22624494

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56114522A Pending JPS5753410A (en) 1980-07-23 1981-07-23 A type hepatitis virus high value production

Country Status (11)

Country Link
US (1) US4301249A (Direct)
EP (1) EP0044793B1 (Direct)
JP (1) JPS5753410A (Direct)
AT (1) ATE20250T1 (Direct)
CA (1) CA1187413A (Direct)
DE (1) DE3174765D1 (Direct)
DK (1) DK326781A (Direct)
ES (1) ES504199A0 (Direct)
GR (1) GR74594B (Direct)
IE (1) IE51454B1 (Direct)
PT (1) PT73371B (Direct)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010004802A (ja) * 2008-06-26 2010-01-14 Toyobo Co Ltd 感染性c型肝炎ウイルス粒子の製造方法、およびその利用
JP5327793B2 (ja) * 2006-09-26 2013-10-30 国立大学法人京都大学 肝炎ウイルスの増殖方法、及びその利用

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783407A (en) * 1985-09-30 1988-11-08 Merck & Co., Inc. Growth of hepatitus A virus in vero cells
DE3633550A1 (de) * 1986-10-02 1988-04-14 Behringwerke Ag Vaccine gegen hepatitis a
US5268292A (en) * 1988-06-27 1993-12-07 Robertson Betty H Reproducible generation of high yields of hepatitis A virus by cell culture
WO1992010564A1 (en) * 1990-12-13 1992-06-25 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Sustained and continuous production of high titers of recombinant viral vectors and transduced target cells for use in gene therapy
US5506129A (en) * 1991-05-24 1996-04-09 Evans Medical Limited Virus production
DZ1706A1 (fr) * 1992-08-07 2002-02-17 Merck & Co Inc Vaccin contre le virus de l'hepatite a.
US5354692A (en) * 1992-09-08 1994-10-11 Pacific Biotech, Inc. Analyte detection device including a hydrophobic barrier for improved fluid flow
HRP950097A2 (en) * 1994-03-08 1997-06-30 Merck & Co Inc Hepatitis a virus culture process
US5498537A (en) * 1994-03-09 1996-03-12 Cellco, Inc. Serum-free production of packaged viral vector
US20020182730A1 (en) * 1995-07-26 2002-12-05 Micheal L. Gruenberg Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
FR2821947B1 (fr) * 2001-03-12 2003-05-16 Canon Kk Procede et dispositif de validation de parametres definissant une image
US20030134341A1 (en) * 2001-09-19 2003-07-17 Medcell Biologics, Llc. Th1 cell adoptive immunotherapy
US20030134415A1 (en) * 2001-09-19 2003-07-17 Gruenberg Micheal L. Th1 cell adoptive immunotherapy
US20030175272A1 (en) * 2002-03-07 2003-09-18 Medcell Biologics, Inc. Re-activated T-cells for adoptive immunotherapy
CA2480121C (en) * 2002-03-27 2012-02-28 Immunex Corporation Methods for increasing polypeptide production
CN101688186A (zh) * 2007-05-04 2010-03-31 巴克斯特国际公司 用于病毒增殖的两阶段温度分布
CA2829774C (en) 2011-03-14 2019-09-24 National Research Council Of Canada Method of viral production in cells

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821087A (en) * 1972-05-18 1974-06-28 Dedrick R Cell culture on semi-permeable tubular membranes
US3883393A (en) * 1972-05-18 1975-05-13 Us Health Education & Welfare Cell culture on semi-permeable tubular membranes
US3997396A (en) * 1973-07-02 1976-12-14 Monsanto Company Method for the in vitro propagation and maintenance of cells
JPS52125688A (en) * 1976-04-12 1977-10-21 Monsanto Co Method and reaction container for coltivating cell
JPS5548389A (en) * 1978-08-17 1980-04-07 Merck & Co Inc In vitro cell culturing of hepatitis a virus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3615024A (en) * 1968-08-26 1971-10-26 Amicon Corp High flow membrane
FR2398504A1 (fr) 1977-07-29 1979-02-23 Tours Inst Virologie Culture de virus de l'hepatite a, in vitro. application a la production d'un antigene reactif, d'immunserums specifiques et de vaccins contre l'hepatite a
US4301250A (en) * 1979-11-02 1981-11-17 Merck & Co., Inc. Method of producing hepatitis B surface antigen

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821087A (en) * 1972-05-18 1974-06-28 Dedrick R Cell culture on semi-permeable tubular membranes
US3883393A (en) * 1972-05-18 1975-05-13 Us Health Education & Welfare Cell culture on semi-permeable tubular membranes
US3997396A (en) * 1973-07-02 1976-12-14 Monsanto Company Method for the in vitro propagation and maintenance of cells
JPS52125688A (en) * 1976-04-12 1977-10-21 Monsanto Co Method and reaction container for coltivating cell
JPS5548389A (en) * 1978-08-17 1980-04-07 Merck & Co Inc In vitro cell culturing of hepatitis a virus

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5327793B2 (ja) * 2006-09-26 2013-10-30 国立大学法人京都大学 肝炎ウイルスの増殖方法、及びその利用
JP2010004802A (ja) * 2008-06-26 2010-01-14 Toyobo Co Ltd 感染性c型肝炎ウイルス粒子の製造方法、およびその利用

Also Published As

Publication number Publication date
IE51454B1 (en) 1986-12-24
ES8205016A1 (es) 1982-05-16
DK326781A (da) 1982-01-24
PT73371A (en) 1981-08-01
CA1187413A (en) 1985-05-21
IE811655L (en) 1982-01-23
PT73371B (en) 1983-06-15
ES504199A0 (es) 1982-05-16
EP0044793B1 (en) 1986-06-04
EP0044793A2 (en) 1982-01-27
US4301249A (en) 1981-11-17
ATE20250T1 (de) 1986-06-15
GR74594B (Direct) 1984-06-29
DE3174765D1 (en) 1986-07-10
EP0044793A3 (en) 1983-01-05

Similar Documents

Publication Publication Date Title
JPS5753410A (en) A type hepatitis virus high value production
IE882407L (en) Purifying hepatitis a virus
TR22917A (tr) Toprak disi tarima mahsus dayanak
DE3260046D1 (en) Method of producing hepatitis b surface antigen
GB2017077B (en) Producing optical fibre preform
ES445716A1 (es) Procedimiento para preparar n-acil-l-metionina opticamente pura.
DE3685764D1 (de) Antibiotikum hergestellt von lysobacter sp. sc 14,067.
FI891133L (fi) Anordning och verktyg foer tillverkning av alla kaenda gaengtyper (med undantag av saoggaengor) i ett arbetsmoment.
ATE10806T1 (de) Verfahren zur herstellung von hepatitis boberfl[chenantigen.
IE781315L (en) Virus cultivation
FI853618A0 (fi) Stabilisering av enzymer anvaendbara foer produktion av glukoson och i andra enzymatiska processer.
ES2028968T3 (es) Sistema de gobierno de la produccion.
EP0394386A4 (en) Method for producing native hiv gp160
IT8748597A0 (it) Procedimento per ottenere 2,2-dimetil-1,3 -propandiolo(npg)puro
DK702288D0 (da) Dihydropyranderivater
USD270206S (en) Scarf
EP0316189A3 (en) Ir-radiation source and method for producing same
JPS5430858A (en) Hologram recorder-reproducer
EP0248425A3 (en) Emitter with a transistorized push-pull output stage
GR880100042A (el) Παραγωγα πυλοκαρπινης
DK0403015T3 (da) Fremgangsmåde til dyrkning af celler
MX9203199A (es) Cultivo biologicamente puro de actinoplanos capaces de producir antibiotico a/16686.
GR862720B (en) Fermentation methods for hepatitis vaccine production
JPS56135031A (en) Assembly of mold for formation of plastic lens
BG28718A3 (bg) Метод за получаване на кортикоиди